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Abstract
Increasing evidence shows that the overproduction of reactive oxygen species, induced by diabetic hyperglycemia, contrib-
utes to the development of several cardiopathologies. The susceptibility of diabetic hearts to oxidative stress, induced in vitro
by ADP-Fe2+ in mitochondria, was studied in 12-month-old Goto-Kakizaki rats, a model of non-insulin dependent diabetes
mellitus, and normal (non-diabetic) Wistar rats. In terms of lipid peroxidation the oxidative damage was evaluated on heart
mitochondria by measuring both the O2 consumption and the concentrations of thiobarbituric acid reactive substances. Dia-
betic rats display a more intense formation of thiobarbituric acid reactive substances and a higher O2 consumption than non-
diabetic rats. The oxidative damage, assessed by electron microscopy, was followed by an extensive effect on the volume of
diabetic heart mitochondria, as compared with control heart mitochondria. An increase in the susceptibility of diabetic heart
mitochondria to oxidative stress can be explained by reduced levels of endogenous antioxidants, so we proceeded in determin-
ing α-tocopherol, GSH and coenzyme Q content. Although no difference of α-tocopherol levels was found in diabetic rats as
compared with control rat mitochondria, a significant reduction in GSH (21.5% reduction in diabetic rats) and coenzyme Q
levels of diabetic rats was observed. The data suggest that a significant decrease of coenzyme Q9, a potent antioxidant involved
in the elimination of mitochondria-generated reactive oxygen species, may be responsible for an increased susceptibility of
diabetic heart mitochondria to oxidative damage. (Mol Cell Biochem 246: 163–170, 2003)
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Introduction
Diabetes mellitus Type 2 or non-insulin-dependent diabetes
mellitus (NIDDM) is a metabolic disorder characterised by
hyperglycemia due to a decrease in the response of periph-
eral tissues (e.g. liver, skeletal muscle, adipose tissue, pan-
creatic β-cells) to insulin [1]. It has been well established that
patients with diabetes mellitus, exhibit a high incidence of
cardiac dysfunction and mortality [2]. Clinical studies sug-
gested that diabetic patients have a significantly greater in-
cidence and severity of several cardiopathies (e.g. angina,
acute myocardial failure, atherosclerosis) [3,  4], and approxi-
mately 80% of all patients with diabetes die of cardiovascu-
lar disease [3].
Mitochondria play an important role in the development
of NIDDM, which agrees with an age-related decline in the
capacity for oxidative phosphorylation, and consequently
contributes to its pathophysiology [5, 6]. In several animal
models, a relationship has been established between diabe-
tes and some dysfunctions in mitochondrial oxidative events
[7, 8], suggesting the occurrence of bioenergetic alterations
at the mitochondrial level [7, 9]. Mitochondria which play
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an important role in cell function, appear to constitute one of
the main sources of reactive oxygen species (ROS) [10, 11]. It
has been estimated that up to 2% of the total mitochondrial
oxygen consumption results in ROS generation [9, 11]. Mito-
chondria are also the cellular component most extensively
affected by increased concentrations of ROS. The inner mi-
tochondrial membrane is believed to be particularly suscepti-
ble to oxidative damage even under physiological conditions
because it is a major site of ROS production and has a high
content in polyunsaturated fatty acids (PUFA) [9, 10]. ROS
generated in the electron transport chain of mitochondria may
react with PUFA which cause lipid peroxidation and alterations
in the structure integrity of mitochondrial membranes, caus-
ing irreversible swelling and disruption, which are a cause of
perturbation of mitochondrial functions [12–14]. Oxidative
damage is suspected to be involved in the pathogenesis of
several diseases (for review see [9]) particularly in myocar-
dial injury and several reports indicate that oxidative stress
could be responsible for the susceptibility of diabetic heart
to cardiopathies [6, 7, 15].
Vitamin E (α-tocopherol), an unsaturated lipid found in the
heart mitochondrial membrane, was reported to display an
higher antioxidant activity, by inhibiting lipid peroxidation
[16]. In the presence of lipoperoxides α-tocopherol (TOH)
can donate one electron, and create a tocopheroxyl radical
(TO•) which can be reduced back to TOH by ascorbate or co-
enzyme Q (CoQ) [17]. The abundant occurrence of CoQ in
mitochondria, due to is role in mitochondrial electron trans-
port, indicates CoQ as a preferential regenerator of α-toco-
pherol [17]. However, research from several groups reported
that the antioxidant effects of CoQ are independent of α-to-
copherol recycling [17, 18]. The emergence of CoQ as an
antioxidant has a special meaning since it is the only lipid-
soluble antioxidant known, so far, that is manufactured by the
human body [18, 19].
The Goto-Kakizaki (GK) rat has been raised as a non-obese
animal model of NIDDM. This animal is spontaneously dia-
betic, is obtained by selective inbreeding of normal Wistar
rats with the highest glucose values during oral glucose toler-
ance tests [20]. The GK rat exhibits a moderate but stable
fasting hyperglycemia, as early as 2–4 weeks after birth,
which does not progress to the ketotic state. Our work evalu-
ates the susceptibility of heart mitochondria from Goto-Kaki-
zaki rats and normal Wistar rats to oxidative stress injury
induced by the oxidant pair ADP/Fe2+, as well as the contri-
bution of the antioxidant defenses.
Materials and methods
This study conforms with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85–23, revised 1996).
Chemicals
Ubiquinone 10 (CoQ10) was obtained from Fluka (Germany),
ubiquinone 9 (CoQ9) and α-tocopherol were obtained from
Sigma Chemicals (St. Louis, MO, USA). All other chemicals
used were of analytical grade.
Animals and blood glucose determination
Male spontaneously diabetic GK rats (46–54 weeks of age;
body wt. 384.7 ± 2.4 g; non-fasting blood glucose levels
198.6 ± 13.5 mg/dl) were obtained from a local breeding
colony of Coimbra, established in 1995 with breeding cou-
ples from the colony at the Tohoku University School of
Medicine (Sendai, Japan; courtesy of Dr. K.I. Susuki). Con-
trol animals were non-diabetic male Wistar rats of similar
age (44–53 weeks of age; body wt. 672.5 ± 60.5 g; non-fast-
ing blood glucose levels 93.4 ± 2.9 mg/dl) obtained from
our local colony. Animals were kept under controlled light
and humidity conditions and with free access to powdered
rodent chow (diet CRF 20; Charles Rivers, France) and wa-
ter. Glucose tolerance test was used as a selection index.
Blood glucose levels were determined, immediately after
animal’s sacrifice, through the glucose oxidase reaction,
using a glucometer (Glucometer Elite, Bayer, Portugal).
Isolation of rat heart mitochondria
Mitochondria were isolated by the conventional differential
centrifugation method from the hearts of Wistar and GK rats
[21], with some modifications. The animals were killed by
decapitation and the heart was immediately excised and
finely minced with a pair of sharp scissors in an ice-cold iso-
lation medium containing 250 mM sucrose, 1 mM EGTA, and
5 mM HEPES–KOH, pH 7.4. The minced blood-free tissue
was then resuspended in 5 ml of isolation medium and trans-
ferred to a 50-ml glass homogenizer vessel and homogenized
with a tightly fitted Potter–Elvehjen homogenizer and a Te-
flon pestle driven by a motor, during 30 sec. Protease (1 mg
subtilisine prepared in 1 ml of isolation medium) was added
and the suspension was re-homogenized for an additional 30
sec. Finally 30 ml medium was added, followed by a last 30-
sec period homogenization. The homogenate was equally di-
vided into two 50 ml centrifuge tubes and each aliquot was
made up to 40 ml with isolation medium and centrifuged at
11,000 × g for 10 min. The supernatant fluid was com-
pletely decanted and the pellet, devoid of protease, was
gently homogenized to its original volume with isolation
medium using a loose-fitting homogenizer. The suspension
was centrifuged at 900 × g during 10 min and the obtained
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low-speed supernatant was transferred through two layers of
cheesecloth to different centrifuge tubes and submitted to
centrifugation at 9000 × g for 10 min. The high-speed super-
natant was discarded and the pellet was resuspended using a
paintbrush and repelleted at 9000 × g for 10 min. EGTA was
omitted from the final washing medium. Mitochondria were
resuspended in isolation medium (without EGTA) in a final
concentration of 20–40 mg/ml.
All the isolation procedure was performed at 0–4°C and
the mitochondrial suspension was maintained on ice (0–
4°C) throughout the assays. The concentration of mitochon-
drial membrane proteins was estimated according to the
biuret method [22], using bovine serum albumin as stand-
ard.
Induction and assay of lipid peroxidation
Lipid peroxidation in rat heart mitochondria was measured
polarographically by monitoring the rates of oxygen con-
sumption with an YSI 5300 oxygen monitor (Yellow Spring
Instruments) equipped with a Clark oxygen electrode, as pre-
viously described [23]. Reaction was run at 30°C in a 1-mL
reaction chamber equipped with magnetic stirring and con-
taining 1 mL medium (175 mM KCl, 10 mM Tris-HCl, pH
7.4), supplemented with 3 µM rotenone and 1 mg mitochon-
drial protein. After 1-min pre-incubation, peroxidation was
started by adding 1 mM ADP and 0.1 mM FeSO4. The oxy-
gen solubility at 30°C was considered 232 µM when the
medium was air-equilibrated at 760 Torr.
Lipid peroxidation was also measured by determining the
amount of lipid peroxides formed during incubation as the
amount of thiobarbituric acid reactive species (TBARS)
formed, according to a modified procedure described by Ern-
ster and Nordenbrand [24]. Mitochondrial protein (1 mg) was
incubated for 45 min, at 30°C, in 1 ml of a medium consisting of
175 mM KCl, 10 mM Tris-HCl, pH 7.4, supplemented with 3 µM
rotenone. Membrane lipid peroxidation was started by add-
ing simultaneously ADP/FeSO4 (1 mM/0.1 mM). Lipoperox-
idation was interrupted by placing the tubes in ice, which
lowered the temperature to 0–4°C. To measure lipid peroxi-
dation, 0.5 mL of cold 40% trichloroacetic acid and 2 mL of
0.67% TBA containing 6.8 mM 2,6-diterbutyl-4-methylphenol
(BHT) were added to 0.5 mL of the test material. The mixture
was heated at 100°C during 10 min, and was allowed to cool
in ice before centrifugation in a bench centrifuge (1500 × g,
5 min). The supernatant was collected and lipid peroxidation
was estimated by the appearance of TBARS spectropho-
tometrically quantified at 535 nm. The amount of TBARS
formed was calculated using a molar extinction coefficient
of 1.56 × 105 M–1 cm–1 and expressed as nmol TBARS/mg
protein [25].
Extraction and quantification of coenzyme Q and α-
tocopherol
CoQ were extracted from aliquots of mitochondria containing
1 mg protein/ml according to the previously described method
[26]. The extract was evaporated to dryness under a stream
of N2, and suspended in ethanol for HPLC analysis. Liquid
chromatography was performed using a Gilson high-perform-
ance liquid chromatography apparatus with a reverse phase
column (RP18; Spherisorb; S5 ODS2) as earlier described [27].
Samples were eluted from the column with methanol:heptane
(10:2, by volume), at a flow of 2 ml/min. Detection was per-
formed with a UV detector, at 269 nm. Identification and quan-
tification were based in pure standards by their retention times
and peak areas, respectively. CoQ levels (CoQ9 and CoQ10) in
mitochondrial membranes were expressed in pmol/mg protein.
The extraction and separation of α-tocopherol was per-
formed following the method described by Vatassery et al.
[28]. The extract, evaporated to dryness under a stream of N2
and kept at –80ºC, was dissolved in n-hexane and the α-to-
copherol contents was analyzed by reverse phase HPLC. A
4.6 × 200 mm Spherisob S10w column was eluted with n-
hexane modified with 0.9% methanol, at a flow of 1.5 ml/min.
Detection was performed with a UV detector, at 287 nm. The
levels of α-tocopherol in mitochondrial membranes were ex-
pressed in pmol/mg protein.
Assay for GSH contents in mitochondria
Determination of GSH in samples were carried out with fluo-
rescence detection after reaction of the supernatant of the
H3PO4/EDTA-NaH2PO4 deproteinized mitochondria solution
with the reagent o-phthaldeyde, at pH 8.0, according to Hissin
and Hilf [29].
Electron microscopy
Mitochondria were fixed for electron microscopy by adding
3% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH
7.3, and were incubated during 2 h at 4°C. After centrifuga-
tion (15,000 × g, 3 min), pellets were washed with 0.1 M so-
dium cacodylate buffer (pH 7.3). The fixed and washed pellet
was resuspended in 1% OsO4 buffered with sodium cacodylate
0.1 M, pH 7.3. After a 2 h incubation, membranes were washed
with cacodylate buffer pH 7.3 (without osmium tetroxide).
Following pre-inclusion in 1% agar, the samples were dehy-
drated in grade ethanol and were embedded in Spurr. The
ultrathin sections were obtained with a LKB ultra-microtome
Ultrotome III and stained with methanolic uranyl acetate
followed by lead citrate and examined with a Jeol Jem-100SX
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electron microscope operated at 80 kV. For quantitative stud-
ies, ultrathin sections from 4 blocks were obtained and 5 mi-
crographs were taken at random on them. So, 20 micrographs
with the final magnification of ×20,000 from peroxidized mito-
chondria and the same number from control mitochondria
were analyzed. The relative volumes of mitochondria were
calculated according with the Weibel method [30], for which
a test area 14 × 13.5 cm was used. This grid contains 112 lines
of 1 cm doing 224 points and the total line length of 112 cm.
Data analysis and statistics
Data are presented as mean ± S.E.M. of the indicated number
of experiments, each one obtained from a different animal.
Statistical evaluation was performed using the paired Stu-
dent’s t-test and by using the one way ANOVA Student–
Newmann–Keuls post-test for multiple comparisons. Values
of p < 0.05 were considered significant.
Results
Mitochondrial lipid peroxidation
Heart mitochondria isolated from diabetic GK rats show a
higher susceptibility to lipid peroxidation induced by ADP/
Fe2+, as assessed by the oxygen consumption (Fig. 1) and the
TBARS production (Fig. 2), when compared to Wistar con-
trol rats. The time-dependent change in peroxidation related
to oxygen concentrations of heart mitochondria was differ-
ent in preparations isolated from diabetic rats compared to
control rats. In both mitochondrial preparations a slow oxy-
gen consumption occurred for several minutes after ADP-Fe2+
addition, after which oxygen consumption drastically in-
creased. When mitochondria begun to peroxidize, it occurred
at the same rate as control mitochondria. As shown on Fig.
2, there was no variation in the absolute mean of TBARS lev-
els in non-oxidized mitochondria from Wistar and GK rats
(0.78 ± 0.69 and 0.97 ± 0.69 nmol/mg protein, respectively).
In the presence of ADP/Fe2+ both mitochondrial fractions
showed a marked increase in TBARS, from 0.78 ± 0.69 to
27.49 ± 2.37 nmol/mg protein in Wistar mitochondria and
from 0.97 ± 0.69 to 45.15 ± 2.05 nmol/mg protein in GK
mitochondria, indicating the occurrence of oxidative damage
to mitochondrial lipids induced by the pro-oxidant pair. The
analysis of the TBARS production after treatment of mito-
chondria with ADP/Fe2+ showed a higher value in mitochon-
dria from diabetic rats compared with the controls (45.15 ±
2.05 and 27.49 ± 2.37 nmol/mg protein, respectively). A sta-
tistically significant difference (p < 0.05) was determined
between both preparations, indicating a higher susceptibil-
Fig. 1. O2 consumption due to lipid peroxidation induced by ADP/Fe2+ in
rat heart mitochondrial membranes isolated from Wistar and GK rats. Rat
heart mitochondria (1 mg) were incubated at 30°C, for 30 min, in 1 ml of
medium consisting of 175 mM KCl, 10 mM Tris (pH 7.4) supplemented
with 3 µM rotenone. Peroxidation was started by adding 1 mM ADP and
0.1 mM FeSO4. The lines represent typical recordings from seven different
experiments.
Fig. 2. TBARS formed in vitro during lipid peroxidation induced by ADP/
Fe2+ in rat heart mitochondria of control (Wistar) and diabetic (GK) rats
induced by ADP/Fe2+ (1 mM/0.1 mM). Rat heart mitochondria (1 mg) were
incubated in 1 ml of medium consisting of 175 mM KCl, 10 mM Tris (pH
7.4) supplemented with 3 µM rotenone, at 30°C, for 2 min. Peroxidation
was started by adding 1 mM ADP and 0.1 mM FeSO4 and incubated for 45
min. TBARS were determined at the end of each incubation period as de-
scribed in Materials and methods, and were expressed as nmol TBARS/mg
protein. Data are expressed as mean ± S.E.M. of seven independent experi-
ments. Statistical significance: *p < 0.05 compared with control group; **p
< 0.05 compared with Wistar rats.
167
ity to induced oxidative stress in diabetic heart mitochondria.
Electron microscopy of mitochondria after oxidative
stress
Heart mitochondria isolated from Wistar and GK rats were
exposed to oxidative attack by ADP-Fe2+ and structural-mor-
phological changes were examined by electron microscopy.
Mitochondria incubated in the absence of ADP-Fe2+ at 30°C
maintained their inner envelope membrane intact but, in the
presence of ADP-Fe2+, membrane discontinuities and volume
fluctuations were observed, as compared to control mitochon-
dria (not shown). In both mitochondrial fractions, swelling
was followed by vesiculation of the inner membrane, and
crenellation of the outer membrane coupled to its dissociation
from the inner membrane. Based on several electron micro-
graphs, the volume of rat heart mitochondria from Wistar and
GK rats were measured, before and after induction of oxi-
dative stress (Fig. 3). Control mitochondria from Wistar rats
displayed a statistically different average volume from dia-
betic rat mitochondria (1.73 ± 0.21 and 1.17 ± 0.14 µm3, re-
spectively). Wistar mitochondria incubated with ADP-Fe2+
(oxidized mitochondria) presented a significantly larger vol-
ume (2.84 ± 0.31 µm3), compared to control non-oxidized
mitochondria (1.73 ± 0.21 µm3). A drastic increase in the
volume can be seen when comparing GK heart oxidized mito-
chondria to non-oxidized GK heart mitochondria (3.1 ± 0.59
and 1.17 ± 0.14 µm3, respectively). Additionally, no statisti-
cal difference was found when we compared oxidized Wi-
star to oxidized GK heart mitochondria (2.84 ± 0.31 and 3.1
± 0.59 µm3, respectively).
Mitochondrial non-enzymatic antioxidants
Mitochondrial non-enzymatic contents in both preparations
were determined: CoQ (Fig. 4), vitamin E (Fig. 5) and GSH
(data not shown). Vitamin E (α-tocopherol), GSH and CoQ,
as assessed by the two main homologues CoQ9 and CoQ10,
are effective inhibitors of membrane lipid peroxidation. In
heart mitochondria of Wistar and GK rats, CoQ9 represents
96% while CoQ10 represents only 4% of the total pool of
mitochondrial CoQ (7.21 ± 0.354 and 5.76 ± 0.64 nmol/mg
protein, respectively). The content of α-tocopherol in mito-
chondria from control and diabetic rats display no significant
differences (1051.0 ± 193.5 and 1051.7 ± 132.1 pmol/mg
protein, respectively), but the GSH contents were significantly
(p < 0.05) lowered, by 21.5%, in GK rat mitochondria com-
pared to Wistar rat mitochondria (1.42 ± 0.12 and 1.86 ± 0.22
pmol/mg protein, respectively). Additionally, the CoQ10 con-
tents have shown no statistical differences between both
preparations (0.29 ± 0.039 and 0.23 ± 0.048 nmol/mg, re-
spectively). However, CoQ9 and consequently, total CoQ
(CoQ9 + CoQ10) contents was significantly different (p < 0.05)
in both mitochondrial preparations (Fig. 4).
Discussion
NIDDM has been studied in several animal models includ-
ing the GK rat, which was selected for this study because it
represents a good model of hereditary non-obese NIDDM
that develops into a moderate and stable diabetic state with
age [20, 31]. Several reports showed that increased levels of
glucose found in NIDDM patients are responsible not only
Fig. 3. Average volume of heart mitochondria isolated from Wistar and GK
rats, before (control mitochondria) and after (oxidized mitochondria) induc-
tion of oxidative damage by ADP/Fe2+ (1 mM/0.1 mM). Data are expressed
as mean ± S.E.M. of seven independent experiments. Statistical significance:
*p < 0.05 compared with Wistar-control group; **p < 0.05 compared with
GK-control rats.
Fig. 4. Coenzyme Q9 (CoQ9) and Q10 (CoQ10) levels in heart mitochondria
isolated from Wistar and GK rats. Coenzyme Q levels were measured by
HPLC as described in Materials and methods. Data are the mean ± S.E.M.
for seven different samples, each obtained from a different rat. Statistical
significance: **p < 0.05 as compared to control Wistar rats.
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for oxygen free radical generation due to non-enzymatic pro-
tein glycation, autooxidation of glycation products, ascorbic
acid and glucose, but also for changes in tissue content and
activity of antioxidant defense systems [32–38]. Elevated
levels of glycated products induce an increase of lipid/pro-
tein oxidation, that in addition to different levels of antioxi-
dant defences in tissues have been correlated with the extent
of tissue damage at the molecular level [33, 36] and with the
development of chronic complications of diabetes mellitus
[33–35, 38]. Heart tissue has several features that makes it
vulnerable to damage from free radicals such as, abundant
mitochondria which may leak activated species, and a higher
percentage of polyunsaturated fatty acids in mitochondrial
and plasma membranes which are susceptible to lipid peroxi-
dation [10, 39–41]. Oxidative stress due to high levels of
glucose may disrupt the efficiency of mitochondrial electron
transport, reduce ATP availability to cellular function [7, 8,
42] and cause the failure of heart activity as well as myocar-
dial diseases [5, 7].
In this study we found that heart mitochondria isolated
from 12-month-old GK rats and Wistar rats display different
susceptibilities to oxidative stress induced by ferrous ion in
the form of ADP-Fe2+. We observed that oxidative damage
induced in heart mitochondria of diabetic rats showed a sig-
nificant increase of lipid peroxidation (measured by O2 con-
sumption and TBARS formation). The slow O2 consumption
could be result of mitochondrial non-enzymatic antioxidants
consumption or can be ascribed to the formation of an ADP-
Fe3+-O2– (perferryl) complex [23], and presented a similar rate
on both Wistar and GK mitochondria assays. However, the
time required for the rapid O2 uptake (lag time) and the time
required to produce an amount of perferryl complex to in-
duce lipid peroxidation [23] is different when diabetic and
non-diabetic mitochondrial fractions were tested. A short lag
time on GK mitochondrial suspensions indicated a higher
susceptibility to lipid peroxidation. The analysis by electron
microscopy of morphological changes showed that oxidative
stress, induced by ADP-Fe2+, was followed by considerable
number of alterations in heart mitochondria with swelling
more pronounced in diabetic heart mitochondria. This in-
crease susceptibility is correlated with a decrease in mito-
chondrial GSH and CoQ9. The observed decrease in lag phase
and the increase in oxygen consumption and TBARS forma-
tion, are probably due to the lower contents of CoQ and GSH
in GK heart mitochondria. GSH plays a crucial role in the
metabolism of hydroperoxides and free radicals [9, 43]. A
decrease of GSH content in GK heart mitochondria suggest
that diabetic mitochondria could be more susceptible to free
radicals damage.
Recently, it became clear that CoQ in the reduced form
plays an important role as an antioxidant, and that this might
explain its broad distribution in subcellular membranes other
than mitochondria [18, 19, 44, 45]. The study of CoQ con-
tent is very relevant when studying lipoperoxidation because
such a liposoluble antioxidant serves as the first line of de-
fense against lipid peroxidation [18, 46, 47]. The antioxidant
function of CoQ, by directly scavenging radicals [46] or by
indirectly regenerating vitamin E [45, 47, 48] from its oxi-
dized form, may be correlated with the high susceptibility of
diabetic heart mitochondria to oxidative stress. In this study,
the concentration of CoQ9, on a mole base, was estimated to
be more than 5–6 times higher than that of heart mitochon-
dria’s α-tocopherol; in addition CoQ9 levels are statistically
lower on diabetic mitochondria. A decrease of CoQ levels
found in diabetic mitochondria causes a reduction in the anti-
oxidant potential of these membranes and a concomitant in-
crease in the susceptibility to oxidative damage. Vitamin E
(α-tocopherol) is suggested to be the most important endog-
enous antioxidant [47] scavenger of radicals generated in the
presence of Fe2+ by preventing the propagation of lipid per-
oxidation chain reactions [42, 43]. The decreased suscepti-
bility to lipid peroxidation in diabetic rats was not correlated
to α-tocopherol levels, because diabetic and non-diabetic
heart mitochondria did not present statistically different lev-
els.
In conclusion, the present study shows that heart mitochon-
dria from diabetic rats differ significantly from non-diabetic
rats in their susceptibility to undergo lipid peroxidation when
oxidative damage is induced in vitro. A reduced antioxidant
potential is responsible for the greater susceptibility of dia-
betic heart mitochondria to oxidative damage as supported
from the lower CoQ and GSH contents of such mitochon-
dria, despite diabetic mitochondria don’t have different lev-
els of α-tocopherol compared to non-diabetic mitochondria.
Recently, Kucharska et al. [49] reported that a deficit of co-
enzyme Q in heart mitochondria of rats with streptozoto-
cin-induced diabetes mellitus was also associated with an
increased lipoperoxidation. Previous reports from our group
[50] on the susceptibility of brain and liver mitochondrial
Fig. 5. Vitamin E levels of GK and control heart mitochondria preparations.
Vitamin E levels were measured by HPLC as described in Materials and
methods. Data are the mean ± S.E.M. for seven different samples, each
obtained from a different rat.
169
preparations to lipid peroxidation in vitro, showed that GK
mitochondrial preparations from liver had reduced suscep-
tibility to lipoperoxidation while brain had an increase sus-
ceptibility to lipid oxidation, in agreement with the heart
mitochondria results reported in this study. Considering the
high energy requirements of the heart, possible damage to
heart mitochondria induced by oxidative stress could cause
a collapse on the cardiac pool of energetic compounds and
be responsible for the reported impairment of heart function
in diabetes.
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